Purpose: Asthma in the elderly (EA; ≥ 65 years of age) is increasing, adding a heavy socioeconomic burden to the healthcare system. However, little is known about risk factors associated with acute exacerbations in EA patients. The objective of this study was to investigate risk factors for acute exacerbation in EA compared to non-elderly asthma (NEA).
Methods: We combined data from 3 adult asthma cohorts under a unified protocol and database. Asthmatic patients with regular follow-up during a 1-year period were selected from the cohorts to identify the risk factors predicting acute exacerbations in EA compared to NEA.
Results: We selected a total of 1,086 patients from the merged cohort. During the observation period, 503 and 583 patients were assigned to the EA and NEA groups, respectively. The exacerbation rate was 31.0% in the EA and 33.2% in the NEA group. Multivariate logistic regression analysis revealed fixed airway obstruction, chronic rhinosinusitis (CRS), and male sex as independent risk factors for exacerbation in the EA group. In the NEA group, exacerbation increased along with an increase in eosinophil count. Bayesian analysis of the interactions among clinical factors revealed that forced expiratory volume in 1 second/forced vital capacity was directly related to exacerbation in the EA group, and eosinophil count was related to exacerbation in the NEA group.
Conclusions: We suggest that fixed airway obstruction and CRS as the important clinical factors predicting acute exacerbations in EA, whereas in NEA, eosinophil count was the strong predictor of exacerbation.
Keywords: Asthma; airway obstruction; elderly; exacerbation; risk factors.
Copyright © 2020 The Korean Academy of Asthma, Allergy and Clinical Immunology · The Korean Academy of Pediatric Allergy and Respiratory Disease.
Conflict of interest statement
There are no financial or other issues that might lead to conflict of interest
Differences between asthma in young and elderly: results from the COREA study.Respir Med. 2013 Oct;107(10):1509-14. doi: 10.1016/j.rmed.2013.07.016. Epub 2013 Aug 6. Respir Med. 2013. PMID: 23927852 Clinical Trial.
Clinical characteristics of eosinophilic and noneosinophilic asthma in children.Acta Paediatr. 2013 Jan;102(1):53-7. doi: 10.1111/apa.12046. Epub 2012 Nov 1. Acta Paediatr. 2013. PMID: 23113613
Airway inflammation and cellular stress in noneosinophilic atopic asthma.Chest. 2006 May;129(5):1194-202. doi: 10.1378/chest.129.5.1194. Chest. 2006. PMID: 16685009
Antibiotics for exacerbations of asthma.Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD002741. doi: 10.1002/14651858.CD002741.pub2. Cochrane Database Syst Rev. 2018. PMID: 29938789 Free PMC article. Review.
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.Cochrane Database Syst Rev. 2016 Jun 7;(6):CD007524. doi: 10.1002/14651858.CD007524.pub4. Cochrane Database Syst Rev. 2016. PMID: 27272563 Review.
- Garner R, Kohen D. Changes in the prevalence of asthma among Canadian children. Health Rep. 2008;19:45–50. - PubMed
- Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet. 2010;376:803–813. - PubMed
- Moorman JE, Akinbami LJ, Bailey CM, Zahran HS, King ME, Johnson CA, et al. National surveillance of asthma: United States, 2001–2010. Vital Health Stat 3. 2012:1–58. - PubMed
- Tsai CL, Lee WY, Hanania NA, Camargo CA. Age-related differences in clinical outcomes for acute asthma in the United States, 2006–2008. J Allergy Clin Immunol. 2012;129:1252–1258.e1. - PubMed
- Szefler SJ. Asthma across the lifespan: time for a paradigm shift. J Allergy Clin Immunol. 2018;142:773–780. - PubMed